Science & Research
First-Ever Guideline on Cardiovascular-Kidney-Metabolic Syndrome Issued
The American Heart Association and the American College of Cardiology released the first clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome, emphasizing early screening and coordinated care to address interconnected heart, kidney, and metabolic conditions affecting nearly 90% of U.S. adults.
Trilogy Metals Launches 2026 Exploration Program at Alaska's Critical Minerals District
Trilogy Metals Inc. begins its fully funded 2026 summer exploration program at the Upper Kobuk Mineral Projects in Alaska, aiming to advance the high-grade Arctic copper project toward a construction decision.
MAX Power Mining Highlights Natural Hydrogen Progress at Global Energy Show Canada
MAX Power Mining Corp. showcases its leadership in natural hydrogen at the Global Energy Show Canada, advancing commercial evaluation at its Saskatchewan project following Canada's first subsurface natural hydrogen discovery.
Canamera Energy Metals Identifies Third Rare Earth Target at Turvolândia Project in Brazil
Canamera Energy Metals Corp. announced a third rare earth target at its Turvolândia project in Brazil, extending the exploration corridor and highlighting the potential for significant ionic clay-hosted rare earth deposits.
Aptevo and Niowave Partner to Advance Radiopharmaceutical Cancer Therapies
Aptevo Therapeutics and Niowave Inc. have formed a 50/50 strategic collaboration to develop up to three radiopharmaceutical oncology programs, combining Aptevo's targeting platforms with Niowave's isotope supply capabilities to address a $17 billion market.
BOXABL Unveils Conceptual ‘UFO’ Habitat for Lunar and Planetary Settlements
BOXABL introduced a conceptual off-world habitation system called the UFO (Unidentified Folding Object), designed to address challenges of transporting and deploying livable structures beyond Earth, with plans to make its intellectual property available royalty-free to spur innovation.
Treble Technologies and Hugging Face Launch First Open Benchmark for Far-Field ASR Models
The new Far Field ASR Leaderboard allows developers to evaluate speech recognition models under realistic acoustic conditions, addressing a key gap in voice AI performance.
Radioactive Collagen Tiles Reduce Brain Cancer Recurrence in Clinical Trial
A clinical trial found that placing radioactive collagen tiles into the brain cavity during tumor removal dramatically cuts recurrence and extends survival, offering new hope for brain cancer treatment.
Regentis Biomaterials Set to Begin European Surgeon Training for GelrinC Cartilage Implant
Regentis Biomaterials plans to commence surgeon training activities in Q3 2026 to support the commercial rollout of its CE Mark-approved GelrinC treatment for knee cartilage lesions, addressing a significant unmet need in Europe.
Quantum BioPharma Advances Multiple Sclerosis Therapy with LUCID-MS Program, Completes Phase 1 Trials
Quantum BioPharma has completed Phase 1 clinical studies for LUCID-MS, a therapy targeting myelin repair in multiple sclerosis, and filed an IND with the FDA, addressing the critical unmet need for neuroprotective treatments.
TransCode Therapeutics to Host R&D Webcast as It Advances Phase 2a Trial for Colorectal Cancer
TransCode Therapeutics will provide strategic and clinical updates during its first live R&D webcast, anchored by its Phase 2a trial of TTX-MC138 in circulating tumor DNA-positive colorectal cancer, highlighting progress in RNA-based oncology treatments.
GeoVax Study Shows Gedeptin May Enhance Checkpoint Inhibitor Responses in Resistant Tumors
Peer-reviewed research in JCI Insight demonstrates GeoVax's Gedeptin platform can sensitize resistant tumors to immune checkpoint inhibitors and activate systemic anti-tumor immunity, potentially broadening cancer immunotherapy efficacy.
Noble Mineral Exploration Launches Summer Drilling on Quebec Critical Minerals Projects
Noble Mineral Exploration Inc. begins Phase 2 surface exploration on rare earth properties in Labrador and Quebec, targeting high-grade REE mineralization critical for clean energy technologies.
Lifordi Immunotherapeutics Reports Positive Phase 1 Data for LFD-200 in Autoimmune Disease
Phase 1 data for LFD-200, a subcutaneous glucocorticoid antibody-drug conjugate, shows anti-inflammatory activity without systemic steroid toxicity, with patient dosing ongoing in rheumatoid arthritis.
HighTide Therapeutics Unveils New Data Supporting HTD1801's Renoprotective Effects at ERA 2026
New findings from HighTide Therapeutics show that its lead candidate HTD1801 protects kidney function by targeting podocyte inflammation and apoptosis, offering potential as a disease-modifying therapy for chronic kidney disease.
Redwood AI Files Patent for Chemical Optimization Technology, Aiming to Reduce R&D Costs
Redwood AI Corp. has filed a provisional patent for a technology that predicts experimental data sufficiency, potentially streamlining chemical R&D across pharmaceuticals, specialty chemicals, and defense.
Oncotelic Therapeutics Advances Nanoparticle Drug Delivery Platform to Improve Cancer Treatment Outcomes
Oncotelic Therapeutics is leveraging its Deciparticle platform and Sapu003 program to enhance drug delivery for existing cancer therapies, addressing key challenges in oncology treatment.
Microglia Protein Production Linked to Pediatric Brain Tumor Spread, Study Finds
Scientists discovered that microglia in the brain produce fibronectin proteins, enabling diffuse midline gliomas to spread, highlighting a potential therapeutic target for companies like CNS Pharmaceuticals.
Spanish Researchers Develop New Material That Could Replace Copper in EVs and Aircraft
Spanish researchers have created a chemically doped carbon nanotube fiber with 17-fold improved conductivity, potentially enabling lighter wiring in electric vehicles, drones, and aircraft.
Oncotelic Therapeutics Highlighted in BioMedWire Editorial as Drug-Delivery Market Nears $410 Billion Opportunity
Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial examining the growing drug-delivery market, highlighting its Sapu003 and Deciparticle platform as nanotechnology-driven approaches to improve existing therapies.
Angkor Resources Begins Drilling at Gossan Hills and Wild Boar Prospects in Cambodia
Angkor Resources has commenced diamond drilling at its Andong Meas license in Cambodia, targeting copper at Gossan Hills and gold at Wild Boar, aiming to advance two key prospects in a single mobilization.
Dr. Robert Whitfield Publishes Safety Research on Fat Transfer Breast Augmentation, Launches Comprehensive BII Health Program
Dr. Robert Whitfield's new BII Health Program pairs explant surgery with fat transfer and offers a non-surgical health optimization program based on the SHARP Method, integrating genetic testing, toxicity assessment, and personalized care.
Quantum BioPharma Builds Diversified Pipeline Targeting Neurological and Wellness Markets
Quantum BioPharma Ltd. advances LUCID-MS for multiple sclerosis and expands into alcohol metabolism with unbuzzd, addressing unmet needs in neurology and wellness.
Oncotelic Therapeutics Expands Sapu003 Phase 1b Program with Global CRO Appointment, Signaling Shift to Multinational Development
Oncotelic Therapeutics and Sapu Nano expand the Phase 1b trial for Sapu003, appointing Global Clinical Trials to lead international execution, marking a transition from an Australia-based study to a multinational strategy.
TransCode Therapeutics Reports Positive Phase 1a Results for TTX-MC138, Paving Way for Phase 2a Trial
TransCode Therapeutics announced positive Phase 1a results for its investigational microRNA-10b inhibitor TTX-MC138, showing durable disease stabilization and no dose-limiting toxicities, supporting advancement to Phase 2a clinical development.
New Pill Daraxonrasib Shows Promise in Doubling Survival for Pancreatic Cancer Patients
Revolution Medicines' daraxonrasib, targeting the KRAS gene, has reportedly doubled survival in early pancreatic cancer trials, offering cautious hope for a disease with limited treatment options.
Onco-Innovations Achieves Kilogram-Scale Manufacturing Milestone for Lead Cancer Drug Candidate
Onco-Innovations Limited successfully produced nearly a kilogram of the B4 precursor for its ONC010 PNKP inhibitor, advancing toward clinical trials and scalable production.
Lexaria Bioscience to Attend BIO International Convention Amid Record Business Development Interest
Lexaria Bioscience Corp. announces its attendance at the BIO International Convention in San Diego, highlighting a surge in partnership interest for its DehydraTECH drug delivery platform, which could lead to significant collaborations with pharmaceutical giants and biotech firms.
GeoVax CEO Sees Renewed Strategic Interest in Vaccine Platforms as Industry Shifts Toward Health Security
GeoVax Labs CEO David Dodd comments on recent pharmaceutical acquisitions, highlighting a strategic shift toward vaccine innovation and health security amid rising global infectious disease threats.
American Heart Association Launches First-Ever Heart Transplant Research Network to Address Innovation Gaps and Inequities
The American Heart Association's new research network, involving 14 centers and a coordinating center, aims to modernize heart transplant care by improving data infrastructure, advancing research, and standardizing quality care to address long-standing disparities and innovation gaps.